These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 23879812

  • 1. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
    Günther C, Blau K, Förster U, Viehweg A, Wozel G, Schäkel K.
    Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
    [Abstract] [Full Text] [Related]

  • 2. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
    Hänsel A, Günther C, Baran W, Bidier M, Lorenz HM, Schmitz M, Bachmann M, Döbel T, Enk AH, Schäkel K.
    J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
    [Abstract] [Full Text] [Related]

  • 3. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM, Koszik F, Reininger B, Kalb ML, Bauer W, Stingl G.
    J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
    [Abstract] [Full Text] [Related]

  • 4. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S, Prakash H, Ebling A, Trenkler N, Wölbing P, Kunze A, Döbel T, Schmitz M, Enk A, Schäkel K.
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [Abstract] [Full Text] [Related]

  • 5. Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.
    Günther C, Starke J, Zimmermann N, Schäkel K.
    Clin Exp Dermatol; 2012 Mar; 37(2):169-76. PubMed ID: 22188261
    [Abstract] [Full Text] [Related]

  • 6. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
    Oehrl S, Olaru F, Kunze A, Maas M, Pezer S, Schmitz M, Schäkel K.
    J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
    [Abstract] [Full Text] [Related]

  • 7. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
    Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H, Chen C, Riblett M, Johnston A, Gudjonsson JE, Helfrich Y, Kang S, Fisher GJ, Voorhees JJ.
    Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549
    [Abstract] [Full Text] [Related]

  • 8. Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients.
    Malaviya R, Sun Y, Tan JK, Wang A, Magliocco M, Yao M, Krueger JG, Gottlieb AB.
    J Am Acad Dermatol; 2006 Oct; 55(4):590-7. PubMed ID: 17010737
    [Abstract] [Full Text] [Related]

  • 9. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
    Wehner R, Löbel B, Bornhäuser M, Schäkel K, Cartellieri M, Bachmann M, Rieber EP, Schmitz M.
    Int J Cancer; 2009 Jan 15; 124(2):358-66. PubMed ID: 18942710
    [Abstract] [Full Text] [Related]

  • 10. [The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].
    Döbel T, Schäkel K.
    J Dtsch Dermatol Ges; 2014 Oct 15; 12(10):874-80. PubMed ID: 25262889
    [Abstract] [Full Text] [Related]

  • 11. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C.
    Int J Immunopathol Pharmacol; 2009 Oct 15; 22(4):961-6. PubMed ID: 20074459
    [Abstract] [Full Text] [Related]

  • 12. Etanercept for psoriasis: two case reports.
    Fidalgo A, Baptista J, Rocha Páris F, Caldas Lopes L, Ferreira A.
    Int J Clin Pharmacol Res; 2005 Oct 15; 25(4):159-63. PubMed ID: 16402631
    [Abstract] [Full Text] [Related]

  • 13. TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.
    Tufa DM, Chatterjee D, Low HZ, Schmidt RE, Jacobs R.
    Eur J Immunol; 2014 Dec 15; 44(12):3717-28. PubMed ID: 25229755
    [Abstract] [Full Text] [Related]

  • 14. Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses.
    Gilles S, Jacoby D, Blume C, Mueller MJ, Jakob T, Behrendt H, Schaekel K, Traidl-Hoffmann C.
    Clin Exp Allergy; 2010 Feb 15; 40(2):269-78. PubMed ID: 20210806
    [Abstract] [Full Text] [Related]

  • 15. Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
    Mager K, Wehner R, Bahr F, Oelschlägel U, Platzbecker U, Wermke M, Shayegi N, Middeke JM, Radke J, Röllig C, Schetelig J, Thiede C, Ehninger G, Schmitz M, Bornhäuser M, Tuve S.
    Transplantation; 2012 Jun 27; 93(12):1270-5. PubMed ID: 22643330
    [Abstract] [Full Text] [Related]

  • 16. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
    Koc E, Tunca M, Akgul EO, Akar A, Kurt Y, Kurumlu Z, Erbil K, Kilic S.
    J Dermatol; 2009 Apr 27; 36(4):191-6. PubMed ID: 19348656
    [Abstract] [Full Text] [Related]

  • 17. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
    Quaglino P, Bergallo M, Ponti R, Barberio E, Cicchelli S, Buffa E, Comessatti A, Costa C, Terlizzi ME, Astegiano S, Novelli M, Cavallo R, Bernengo MG.
    Dermatology; 2011 Apr 27; 223(1):57-67. PubMed ID: 21865674
    [Abstract] [Full Text] [Related]

  • 18. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.
    Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG.
    J Allergy Clin Immunol; 2009 Nov 27; 124(5):1022-10.e1-395. PubMed ID: 19895991
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
    Gerner M, Hölig K, Wehner R, Zhao S, Schäkel K, Bachmann MP, Rieber EP, Bornhäuser M, Schmitz M.
    Transplantation; 2009 Apr 27; 87(8):1134-9. PubMed ID: 19384158
    [Abstract] [Full Text] [Related]

  • 20. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
    Mease PJ.
    Skin Therapy Lett; 2003 Jan 27; 8(1):1-4. PubMed ID: 12728284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.